Favorable impact of long‐term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5‐year follow‐up study

The aim of this study was to determine the impact at 5 years of sodium‐glucose cotransporter 2 inhibitor (SGLT2i) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes mellitus (T2DM) on liver histopathology and clinical features. In this retrospective study, the histological impacts at 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Akuta, Norio, Kawamura, Yusuke, Fujiyama, Shunichiro, Saito, Satoshi, Muraishi, Nozomu, Sezaki, Hitomi, Hosaka, Tetsuya, Kobayashi, Masahiro, Kobayashi, Mariko, Arase, Yasuji, Ikeda, Kenji, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Kumada, Hiromitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426401/
https://www.ncbi.nlm.nih.gov/pubmed/35581956
http://dx.doi.org/10.1002/hep4.2005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426401/
https://www.ncbi.nlm.nih.gov/pubmed/35581956
http://dx.doi.org/10.1002/hep4.2005

Ejemplares similares